Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Zai Lab Ltd ( (HK:9688) ).
Zai Lab Ltd has adopted a new charter for its Nominating and Corporate Governance Committee, which outlines the committee’s purpose, composition, procedures, and responsibilities. This move is aimed at enhancing corporate governance and ensuring the selection of qualified individuals for the board, thereby strengthening the company’s leadership and aligning with Nasdaq and Hong Kong Stock Exchange standards.
The most recent analyst rating on (HK:9688) stock is a Hold with a HK$22.00 price target. To see the full list of analyst forecasts on Zai Lab Ltd stock, see the HK:9688 Stock Forecast page.
More about Zai Lab Ltd
Zai Lab Ltd is a biopharmaceutical company focused on developing and commercializing therapies for oncology, autoimmune, and infectious diseases. The company operates in the global market with a particular emphasis on the Asian region.
Average Trading Volume: 15,369,363
Technical Sentiment Signal: Sell
Current Market Cap: HK$25.45B
Find detailed analytics on 9688 stock on TipRanks’ Stock Analysis page.